Metabolic Syndrome and Cardiovascular Risk Management After Liver Transplantation
Significant improvements to the management of metabolic syndrome after liver transplantation must be made to reduce the risk for CV events and mortality.
Cardiovascular and Metabolic Disorders
CARDIOVASCULAR AND METABOLIC DISORDERS
Featured Article
Latest News
Non-HDL Cholesterol Levels Linked to Long-Term ASCVD Risk
Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years
Changes in Metabolic Syndrome Status Linked to MACE Risk
Recovery from metabolic syndrome is associated with a decreased risk for major adverse cardiovascular events, while increased risk is seen in association with MetS development.
Lipidome Module Associated With Markers of Osteoporosis and Atherosclerosis
Researchers identified a network of lipid species jointly associated with markers of both osteoporosis and atherosclerosis.
Statin Use Not Linked to Rate of Cognitive Decline in Older Adults
Statin therapy is not associated with increased decline in memory or cognition among older adults.
Cost-Related Medication Nonadherence Reported in US Adults With ASCVD
More than 12 percent of patients with atherosclerotic cardiovascular disease report nonadherence to medications due to costs.
Whey Protein Supplementation May Reduce Components of Metabolic Syndrome
Pooled data from a systematic review and meta-analysis indicated that supplementation with whey protein reduced individual components of metabolic syndrome.
AHA: Lower Target for LDL-C Level Beneficial After Ischemic Stroke
For patients with ischemic stroke or transient ischemic attack with evidence of atherosclerosis, those with a target low-density lipoprotein cholesterol level of less than 70 mg/dL have a lower risk for cardiovascular events.
Long-Term Breastfeeding Linked to Lower Risk for Diabetes
Breastfeeding for >12 months was found to be associated with a reduced risk for hypertension and diabetes.
Twice-Yearly Dosing of Inclisiran Provides Significant LDL-C Lowering
Twice-yearly dosing with inclisiran sodium resulted in significant lowering of low-density lipoprotein cholesterol, according to results from the ORION-9 study.
AHA: Predictors of LDL-C Goal Attainment Identified in ISCHEMIA Trial
Predictors of attaining low-density lipoprotein cholesterol and systolic blood pressure goals have been identified.
AHA: Many With Atherosclerotic CVD Not Meeting LDL-C Goals
A high proportion of patients with atherosclerotic cardiovascular disease (ASCVD) do not achieve recommended low-density lipoprotein cholesterol.
Want to read more?
Please login or register first to view this content.
Next post in News
